Skip to main content
. 2015 Jun 12;10(6):e0129991. doi: 10.1371/journal.pone.0129991

Fig 2. Overall Meta-analysis on the VAS Scores.

Fig 2

Patients receiving ALC showed significantly more reduction in VAS scores than those receiving placebo. The values presented referred to the change of VAS scores from baseline. VAS = Visual Analogue Scale; ALC = acetyl-l-carnitine; UCE = U.S.-CanadianEuropean Study; UC = U.S.-Canadian Study; SD = standard deviation; CI = confidence interval.